| Literature DB >> 35566246 |
Mohamed A Abd Elhamid1, Abd Elrahman S Mandour1, Tarek A Ismail1, Ahmed M Al-Zohairy1, Sanaa Almowallad2, Leena S Alqahtani3, Ali Osman4.
Abstract
In the present study, the chemical composition and total phenolic (TPC) and total flavonoid contents (TFC) of eight soybean cultivars (Giza 21, Giza 22, Giza 35, Giza 111, Giza 82, Giza 83, Crawford, and Holliday) were estimated. Moreover, antioxidant activity and in vitro cytotoxic activities against HepG-2 and MCF-7 were evaluated. Giza 21, Giza 111, and Crawford cultivars recorded higher than 40% crude protein. The analysis revealed that TPC values in seed extracts ranged from 10.5 mg GAE/g extract in Giza 35 to 6.4 mg GAE/g extract in Giza 22. TFC varied from 1.20 mg QE/g extract in Giza 111 to 0.55 mg QE/g extract in Crawford. Giza 35 exhibited the highest content of genistein and daidzein and the highest free radical scavenging activity (61.833%). The results of the MTT assay demonstrated that the soybean methanolic extracts inhibited the proliferation of HepG-2 and MCF-7 cells in a dose-dependent manner. Giza 35 exhibited the highest cytotoxic activity. In conclusion, Giza 35 cultivar recorded the highest TPC and TFC values and antioxidant and cytotoxic activities. Therefore, this cultivar can be used as a source for the production of pharmaceutical and medicinal products rather than as a nutritional source of protein.Entities:
Keywords: DPPH assay; MTT assay; cytotoxicity; flavonoids; isoflavones; soybean
Mesh:
Substances:
Year: 2022 PMID: 35566246 PMCID: PMC9104066 DOI: 10.3390/molecules27092895
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Chemical composition of the eight soybean cultivars.
| Cultivar | Constituents of the Sample (%) | |||||
|---|---|---|---|---|---|---|
| Proteins | Carbohydrates | Fat | Ash | Crud Fibre | Moisture | |
| Giza 21 | 43.67 ± 2.00 ab | 21.81 ± 1.00 cd | 19.42 ± 0.89 ab | 4.05 ± 0.19 c | 6.70 ± 0.31 de | 4.35 ± 0.20 cde |
| Giza 22 | 37.48 ± 1.72 c | 26.72 ± 1.22 ab | 19.53 ± 0.90 ab | 4.50 ± 0.20 bc | 6.95 ± 0.32 cde | 4.82 ± 0.27 bcd |
| Giza 35 | 35.17 ± 1.61 c | 23.96 ± 1.09 bc | 20.97 ± 0.96 a | 4.00 ± 0.18 c | 10.85 ± 0.40 a | 5.05 ± 0.23 ab |
| Giza 111 | 44.23 ± 2.03 a | 20.49 ± 0.94 d | 19.13 ± 0.88 ab | 4.25 ± 0.19 c | 6.70 ± 0.31 de | 5.20 ± 0.24 a |
| Crawford | 42.83 ± 1.97 ab | 21.99 ± 1.00 cd | 20.03 ± 0.92 ab | 4.17 ± 0.19 c | 6.14 ± 0.28 e | 4.84 ± 0.22 abc |
| Giza 82 | 39.80 ± 1.83 abc | 25.48 ± 1.17 ab | 18.15 ± 0.83 b | 4.90 ± 0.22 ab | 7.77 ± 0.36 bc | 3.90 ± 0.18 def |
| Giza 83 | 38.85 ± 1.78 bc | 26.95 ± 1.23 ab | 18.96 ± 0.87 ab | 4.32 ± 0.20 bc | 7.17 ± 0.33 bcd | 3.75 ± 0.17 ef |
| Holliday | 37.05 ± 1.70 c | 27.70 ± 1.27 a | 18.40 ± 0.85 b | 5.16 ± 0.23 a | 7.94 ± 0.36 b | 3.57 ± 0.16 f |
| <0.001 | <0.001 | 0.029 | <0.001 | <0.001 | <0.001 | |
All data are expressed as the mean (n = 3) with ±SD in the same column; the a–f letters indicate significant differences between means (p < 0.01).
Total phenolic (TPC) and total flavonoid contents (TFC) in eight soybean cultivars extracts.
| Cultivar | TF mg QE/g Extract | TPC mg GAE/g Extract |
|---|---|---|
| Giza 21 | 1.10 ± 0.05 ab | 7.90 ± 0.29 d |
| Giza 22 | 0.75 ± 0.02 c | 6.40 ± 0.30 e |
| Giza 35 | 1.05 ± 0.05 b | 10.50 ± 0.48 a |
| Giza 111 | 1.20 ± 0.06 a | 9.40 ± 0.43 ab |
| Crawford | 0.55 ± 0.03 e | 8.09 ± 0.37 cd |
| Giza 82 | 0.65 ± 0.03 de | 9.02 ± 0.42 bc |
| Giza 83 | 0.56 ± 0.03 e | 10.25 ± 0.47 a |
| Holliday | 0.71 ± 0.03 cd | 7.20 ± 0.33 de |
| <0.001 | <0.001 |
All data are expressed as the mean (n = 3) with ±SD in the same column; the a, b, c, d and e letters indicate significant differences between means (p < 0.01).
Figure 1HPLC of major phenolic, flavonoid, and isoflavone compounds (1: syringic, 2: quercetin, 3: gallic acid, 4: benzoic acid, 5: genistein, 6: daidzein, 7: p-coumaric, 8: glycitein, and 9: ferulic acid) in eight soybean cultivar extracts.
Major phenolic, flavonoid, and isoflavone compounds in the eight soybean cultivar extracts estimated by HPLC.
| Cultivar | Concentration (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Syringic Acid | Quercetin | Gallic Acid | Benzoic Acid | Genistein | Daidzein | Glycitein | Ferulic Acid | ||
| Giza 21 | 0.93 ± 0.06 d | 30.05 ± 1.38 bc | 6.61 ± 0.23 b | 5.25 ± 0.19 b | 25.74 ± 0.89 e | 12.82 ± 0.44 c | 2.82 ± 0.15 c | 10.24 ± 0.18 b | 5.54 ± 0.15 d |
| Giza 22 | 1.31 ± 0.06 a | 29.25 ± 1.34 bc | 6.00 ± 0.21 c | 4.94 ± 0.17 c | 27.72 ± 0.48 cd | 13.11 ± 0.23 c | 3.60 ± 0.17 b | 7.10 ± 0.33 e | 6.97 ± 0.12 c |
| Giza 35 | 0.50 ± 0.03 e | 30.80 ± 1.07 b | 7.79 ± 0.36 a | 1.16 ± 0.12 d | 30.00 ± 0.52 a | 15.07 ± 0.51 ab | 3.85 ± 0.18 b | 8.68 ± 0.31 c | 2.15 ± 0.10 e |
| Giza 111 | 1.06 ± 0.05 c | 37.34 ± 1.59 a | 7.53 ± 0.34 a | Not detected | 25.62 ± 0.89 e | 15.87 ± 0.27 a | 1.87 ± 0.19 d | 3.16 ± 0.16 f | 7.55 ± 0.25 b |
| Crawford | 1.26 ± 0.05 a | 26.44 ± 1.21 d | 6.62 ± 0.31 b | 6.04 ± 0.21 a | 28.79 ± 1.00 bc | 14.67 ± 0.25 b | 4.50 ± 0.16 a | 11.68 ± 0.20 a | Not detected |
| Giza 82 | 0.88 ± 0.02 d | 28.12 ± 1. 09 cd | 4.36 ± 0.18 d | 5.25 ± 0.18 b | 29.74 ± 0.51 ab | 12.82 ± 0.44 c | 2.82 ± 0.13 c | 10.65 ± 0.37 b | 5.36 ± 0.13 d |
| Giza 83 | 1.16 ± 0.03 b | 26.05 ± 0.91 d | 7.50 ± 0.34 a | 5.50 ± 0.25 b | 27.00 ± 0.47 d | 12.26 ± 0.54 c | 3.82 ± 0.13 b | 8.24 ± 0.35 d | 8.47 ± 0.29 a |
| Holliday | 1.33 ± 0.05 a | 29.50 ± 1.02 bc | 5.75 ± 0.26 c | 4.94 ± 0.22 c | 27.70 ± 0.48 cd | 14.41 ± 0.58 b | 3.62 ± 0.20 b | 7.10 ± 0.39 e | 5.65 ± 0.12 d |
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
All data are expressed as the mean (n = 3) with ±SD in the same column; the a, b, c, d and e letters indicate significant differences between means (p < 0.01).
DPPH radical scavenging activity IC50 (µg/mL) of soybean cultivar methanolic extracts.
| Samples | DPPH Radical Scavenging Activity IC50 (µg/mL) |
|---|---|
| Giza 21 | 57 ± 2.01 d |
| Giza 22 | 64 ± 2.43 c |
| Giza 35 | 45 ± 1.56 f |
| Giza 111 | 52 ± 1.80 e |
| Crawford | 61 ± 1.06 c |
| Giza 82 | 81 ± 1.40 a |
| Giza 83 | 55 ± 1.91 de |
| Holliday | 76 ± 2.23 b |
| TBHQ | 62 ± 1.07 c |
| <0.001 |
All data are expressed as the mean (n = 3) with ±SD in the same column; the a, b, c, d, e and f letters indicate significant differences between means (p < 0.01).
The antioxidant activity of soybean cultivars methanolic extract at 800 µg/mL determined as FRAP.
| Cultivars | Ferric Reducing Power (µ Mole Fe+2/g Extract) |
|---|---|
| Giza 21 | 800 ± 40.41 d |
| Giza 22 | 900 ± 40.57 d |
| Giza 35 | 1900 ± 86.22 a |
| Giza 111 | 1400 ± 66.58 b |
| Crawford | 1100 ± 51.32 c |
| Giza 82 | 1200 ± 56.86 c |
| Giza 83 | 1600 ± 72.11 b |
| Holliday | 770 ± 35.12 d |
| TBHQ | 2100 ± 111 a |
| <0.001 |
All data are expressed as the mean (n = 3) with ±SD in the same column; the a, b, c and d letters indicate significant differences between means (p < 0.01).
The percentage of HepG-2 viability as affected by soybean methanolic extracts at different concentrations (12.5, 25, 50, 100, and 200 µg/mL) from eight soybean cultivars compared to that of the control (Doxorubicin).
| Cultivar | Concentration (µg/mL)/Cell Viability (%) | ||||
|---|---|---|---|---|---|
| 12.5 | 25 | 50 | 100 | 200 | |
| Giza 21 | 81 ± 2.81 a | 79 ± 2.74 ab | 68 ± 2.91 f–i | 59 ± 2.04 h–j | 45 ± 2.12 mn |
| Giza 22 | 79 ± 2.74 ab | 76 ± 1.32 a–d | 62 ± 1.07 f–i | 55 ± 2.15 lm | 40 ± 1.39 no |
| Giza 35 | 71 ± 2.92 b–e | 61 ± 2.11 g–i | 45 ± 1.78 mn | 35 ± 1.21 op | 10 ± 1.17 r |
| Giza 111 | 76 ± 2.63 a–d | 68 ± 3.12 d–g | 51 ± 1.88 j–m | 44 ± 1.76 mn | 30 ± 1.04 p |
| Crawford | 79 ± 2.62 ab | 72 ± 1.99 b–e | 58 ± 2.01 h–k | 51 ± 1.77 j–m | 40 ± 2.77 no |
| Giza 82 | 78 ± 1.70 a–c | 70 ± 2.42 c–f | 55 ± 0.95 i–l | 49 ± 2.39 lm | 38 ± 1.32 n–p |
| Giza 83 | 75 ± 2.60 a–d | 66 ± 1.14 e–h | 49 ± 0.85 lm | 40 ± 1.83 no | 21 ± 1.36 q |
| Holliday | 90 ± 1.73 k–m | 80 ± 0.78 mn | 71 ± 2.46 b–e | 60 ± 1.04 g–i | 50 ± 2.29 k–m |
| Doxorubicin | 50 ± 1.15 j–m | 45 ± 0.78 mn | 35 ± 1.60 op | 20 ± 0.92 q | 9 ± 1.31 r |
| ANOVA | |||||
| Cultivar | <0.001 | ||||
| Concentration | <0.001 | ||||
| Cultivar × Concentration | <0.001 | ||||
All data are expressed as the mean (n = 3) with ±SD in the same column; the a–r letters indicate significant differences between means (p < 0.01).
The percentage of MCF-7 viability as affected by soybean methanolic extracts at different concentrations (12.5, 25, 50, 100, and 200 µg/mL) from eight soybean cultivars compared to that of the control (Doxorubicin).
| Cultivar | Concentration (µg/mL)/ Cell Viability (%) | ||||
|---|---|---|---|---|---|
| 12.5 | 25 | 50 | 100 | 200 | |
| Giza 21 | 88 ± 2.10 b | 86 ± 1.49 bc | 75 ± 1.30 f–h | 66 ± 2.29 ij | 50 ± 2.37 n–q |
| Giza 22 | 86 ± 1.94 bc | 83 ± 1.44 b–e | 69 ± 1.20 h–j | 62 ± 2.15 j–l | 47 ± 2.15 p–r |
| Giza 35 | 78 ± 2.27 d–g | 68 ± 2.36 h–j | 50 ± 1.87 | 42 ± 1.45 rs | 20 ± 1.35 uv |
| Giza 111 | 83 ± 1.80 b–e | 75 ± 2.60 f–h | 58 ± 2.01 k–m | 49 ± 1.70 o–r | 36 ± 1.25 s |
| Crawford | 86 ± 2.18 bc | 79 ± 2.62 c–g | 65 ± 2.98 jk | 58 ± 2.26 k–m | 47 ± 2.15 p–r |
| Giza 82 | 85 ± 2.30 b–d | 77 ± 1.33 e–g | 62 ± 1.07 j–l | 52 ± 2.60 m–p | 44 ± 0.76 qr |
| Giza 83 | 82 ± 1.42 b–f | 73 ± 1.26 g–i | 56 ± 0.97 l–o | 47 ± 2.15 p–r | 28 ± 1.28 t |
| Holliday | 97 ± 1.68 a | 87 ± 1.51 b | 78 ± 2.50 d–g | 67 ± 2.32 ij | 58 ± 1.00 k–m |
| Doxorubicin | 57 ± 0.99 l–n | 52 ± 1.80 m–p | 42 ± 1.45 rs | 27 ± 1.47 tu | 16 ± 0.73 v |
| ANOVA | |||||
| Cultivar | <0.001 | ||||
| Concentration | <0.001 | ||||
| Cultivar × Concentration | <0.001 | ||||
All data are expressed as the mean (n = 3) with ±SD in the same column; the a–v letters indicate significant differences between means (p < 0.01).
Figure 2Cytotoxic activity of methanolic extracted from soybean Giza 35 at different concentrations (12.5, 25, 50, 100, and 200 µg/mL) against HepG-2 (A) and MCF-7 (B) compared to that of Doxorubicin as a control. All data are expressed as the mean (n = 3) with ±SD.
Origin and pedigree for the used eight soybean cultivars.
| No. | Accession | Origin | Pedigree |
|---|---|---|---|
| 1 | Giza 21 | Egypt | Crawford × Celest |
| 2 | Giza 22 | Egypt | Crawford × Forrst |
| 3 | Giza 35 | Egypt | Crawford × Celest |
| 4 | Giza 111 | Egypt | Crawford × Celest |
| 5 | Crawford | USA | Williams × Colombus |
| 6 | Giza 82 | Egypt | Crawford × M. Presto |
| 7 | Giza 83 | Egypt | Selected from MBB-133-9 |
| 8 | Holliday | USA | N77-179 × Johnston |